Data / Form D filings / Envision Genomics, Inc.
Envision Genomics, Inc.: Form D filing
Envision Genomics, Inc., a biotechnology company in Huntsville, AL, filed a Form D with the SEC in 2017. The latest, on December 21, 2017, reports $160,000 sold of a $3 million offering to 3 investors.
Find out what Envision Genomics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GENOME WAY, Huntsville, AL, 35806
- Phone
- (256) 327-9770
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1721498
The full lists. Form D filings in Alabama: 291 rows, $14.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 21, 2017 | New notice | $3,000,000 | $160,000 | $2,840,000 | 3 | Dec 10, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Hudson | Director | |
| David Bick | Executive Officer | |
| Elizabeth Worthey | Executive Officer | |
| Bruce Korf | Executive Officer | |
| Jason Chung | Director | |
| Howard Jacob | Director | |
| Thomas Main | Director | |
| Jill Tapper | Executive Officer | |
| Grace Terrell | Executive Officer, Director | |
| Aaron Fisher | Executive Officer |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Dec 18, 2017 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Envision Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.